The China Plasma Fractionation Markets share is positioned for significant evolution as demand for plasma-derived therapies continues to rise. Expected to reach USD 6 billion by 2035, the market is marked by a strong CAGR of 8.02%. The increasing incidence of chronic diseases and advancements in fractionation technologies are pivotal factors driving market dynamics, enabling companies to...